StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

Dichloromethane → Benzyl trans-3-[(tert-butoxycarbonyl)amino]-2-methylpiperidine-1-carboxylate

HRID 1050558
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 1050558
[CH3:1][C@@H:2]1[CH:7]([NH:8][C:9](=[O:15])[O:10][C:11]([CH3:14])([CH3:13])[CH3:12])[CH2:6][CH2:5][CH2:4][NH:3]1.C(Cl)Cl.CCN(C(C)C)C(C)C.Cl[C:29]([O:31][CH2:32][C:33]1[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=1)=[O:30]>O>[C:11]([O:10][C:9]([NH:8][C@@H:7]1[CH2:6][CH2:5][CH2:4][N:3]([C:29]([O:31][CH2:32][C:33]2[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=2)=[O:30])[C@@H:2]1[CH3:1])=[O:15])([CH3:14])([CH3:13])[CH3:12].[C:11]([O:10][C:9]([NH:8][C@@H:7]1[CH2:6][CH2:5][CH2:4][N:3]([C:29]([O:31][CH2:32][C:33]2[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=2)=[O:30])[C@H:2]1[CH3:1])=[O:15])([CH3:14])([CH3:13])[CH3:12]
KomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 4

HCID 6344DichloromethaneHCID 10387Benzyl chloroformateHCID 81531DiisopropylethylamineHCID 118114667(R)-tert-butyl 2-methylpiperidin-3-ylcarbamate

Produkt 2

HCID 59223903(2R,3R)-benzyl 3-(tert-butoxycarbonylamino)-2-methylpiperidine-1-carboxylateAusbeute 19 %
HCID 59224206
Benzyl trans-3-[(tert-butoxycarbonyl)amino]-2-methylpiperidine-1-carboxylate
Ausbeute 61 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 962WaterLösungsmittel

Reaktionsbedingungen

Temperatur
0 °C

Versuchsvorschrift

(R)-tert-Butyl 2-methylpiperidin-3-ylcarbamate (307) (8.2 g, 38 mmol) was suspended in a solution of DCM (500 mL) and DIEA (13.4 mL, 76.9 mmol). Benzyl chloroformate (6.6 mL, 46 mmol) was then added drop-wise over 5 minutes and the reaction was stirred at 0° C. for 30 minutes. Water was then added and the mixture was allowed to come to room temperature and stirred for 30 minutes. The organic phase was separated, washed with 1M HCl (aq), saturated NaHCO3 (aq), and brine. On TLC, the trans-isomer (309) displayed a higher silica Rf value than the cis isomer (308). The two diastereomers were separated by silica flash column chromatography (EtOAc/hexanes). The mixed fractions from the first purification were combined and subjected to a second purification. After two purifications, (2R,3R)-benzyl 3-(tert-butoxycarbonylamino)-2-methylpiperidine-1-carboxylate (308) (2.5 g, 7.2 mmol, 19% yield) and (2S,3R)-benzyl 3-(tert-butoxycarbonylamino)-2-methylpiperidine-1-carboxylate (309) (8 g, 23 mmol, 61% yield) were obtained.

Aufarbeitung

  1. customto come to room temperature
  2. stirringstirred for 30 minutes
  3. customThe organic phase was separated
  4. washwashed with 1M HCl (aq), saturated NaHCO3 (aq), and brine
  5. customThe two diastereomers were separated by silica flash column chromatography (EtOAc/hexanes)
  6. customThe mixed fractions from the first purification
  7. customsubjected to a second purification

Quellen und Nachweise

ORD-Eintrag
ord-c3f56fb6c9604cdd94323fc08010d1d5
Quelldatensatz
uspto-grants-2016_07
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US09382246B2

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion